| 发明名称 |
USE OF THYMOSIN ALPHA 1 FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF STAGE IV MALIGNANT MELANOMA |
| 摘要 |
It is described the use of thymosin alpha in combination with dacarbazine and optionally with Interferon alpha, for preparing a medicament for the treatment of malignant melanoma on stage IV characterized by distant unresectable metastases. |
| 申请公布号 |
IL195955(D0) |
申请公布日期 |
2009.09.01 |
| 申请号 |
IL20080195955 |
申请日期 |
2008.12.15 |
| 申请人 |
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. |
发明人 |
|
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
